[1]
Fitzgibbon GM,Kafka HP,Leach AJ,Keon WJ,Hooper GD,Burton JR, Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. Journal of the American College of Cardiology. 1996 Sep [PubMed PMID: 8772748]
[2]
Sanz G,Pajarón A,Alegría E,Coello I,Cardona M,Fournier JA,Gómez-Recio M,Ruano J,Hidalgo R,Medina A, Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC) Circulation. 1990 Sep [PubMed PMID: 2203555]
[3]
Gavaghan TP,Gebski V,Baron DW, Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. Circulation. 1991 May [PubMed PMID: 2022014]
[4]
The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. The New England journal of medicine. 1997 Jan 16 [PubMed PMID: 8992351]
[5]
Campeau L,Hunninghake DB,Knatterud GL,White CW,Domanski M,Forman SA,Forrester JS,Geller NL,Gobel FL,Herd JA,Hoogwerf BJ,Rosenberg Y, Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators. Circulation. 1999 Jun 29 [PubMed PMID: 10385497]
[6]
Boekholdt SM,Hovingh GK,Mora S,Arsenault BJ,Amarenco P,Pedersen TR,LaRosa JC,Waters DD,DeMicco DA,Simes RJ,Keech AC,Colquhoun D,Hitman GA,Betteridge DJ,Clearfield MB,Downs JR,Colhoun HM,Gotto AM Jr,Ridker PM,Grundy SM,Kastelein JJ, Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials. Journal of the American College of Cardiology. 2014 Aug 5 [PubMed PMID: 25082583]
[9]
Marmagkiolis K,Grines C,Bilodeau L, Current percutaneous treatment strategies for saphenous vein graft disease. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography [PubMed PMID: 22777812]
[11]
Shi Y,O'Brien JE Jr,Mannion JD,Morrison RC,Chung W,Fard A,Zalewski A, Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation. 1997 Jun 17 [PubMed PMID: 9193438]
[13]
Lüscher TF,Diederich D,Siebenmann R,Lehmann K,Stulz P,von Segesser L,Yang ZH,Turina M,Grädel E,Weber E, Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. The New England journal of medicine. 1988 Aug 25 [PubMed PMID: 3136329]
[14]
Kockx MM,De Meyer GR,Bortier H,de Meyere N,Muhring J,Bakker A,Jacob W,Van Vaeck L,Herman A, Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts. Circulation. 1996 Sep 15 [PubMed PMID: 8822977]
[18]
Goodney PP,Beck AW,Nagle J,Welch HG,Zwolak RM, National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. Journal of vascular surgery. 2009 Jul [PubMed PMID: 19481407]
[20]
Samano N,Pinheiro BB,Souza D, Surgical Aspects of No-Touch Saphenous Vein Graft Harvesting in CABG: Clinical and Angiographic Follow-Up at 3 Months. Brazilian journal of cardiovascular surgery. 2019 Jan-Feb; [PubMed PMID: 30810681]
[22]
Christie LG Jr,Conti CR, Systematic approach to evaluation of angina-like chest pain: pathophysiology and clinical testing with emphasis on objective documentation of myocardial ischemia. American heart journal. 1981 Nov [PubMed PMID: 7304398]
[23]
Olinic DM,Stanek A,Tătaru DA,Homorodean C,Olinic M, Acute Limb Ischemia: An Update on Diagnosis and Management. Journal of clinical medicine. 2019 Aug 14 [PubMed PMID: 31416204]
[25]
Smith SC Jr,Benjamin EJ,Bonow RO,Braun LT,Creager MA,Franklin BA,Gibbons RJ,Grundy SM,Hiratzka LF,Jones DW,Lloyd-Jones DM,Minissian M,Mosca L,Peterson ED,Sacco RL,Spertus J,Stein JH,Taubert KA, AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. Journal of the American College of Cardiology. 2011 Nov 29 [PubMed PMID: 22055990]
[26]
Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration. BMJ (Clinical research ed.). 1994 Jan 15 [PubMed PMID: 8312766]
[28]
Zhao Q,Zhu Y,Xu Z,Cheng Z,Mei J,Chen X,Wang X, Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial. JAMA. 2018 Apr 24 [PubMed PMID: 29710164]
[31]
Abbruzzese TA,Havens J,Belkin M,Donaldson MC,Whittemore AD,Liao JK,Conte MS, Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. Journal of vascular surgery. 2004 Jun [PubMed PMID: 15192555]
[33]
Barleben A,Bandyk DF, Surveillance and follow-up after revascularization for critical limb ischemia. Seminars in vascular surgery. 2014 Mar [PubMed PMID: 25812761]
[35]
Hoffmann R,Hamm C,Nienaber CA,Levenson B,Bonzel T,Sabin G,Senges J,Zahn R,Tebbe U,Pfannebecker T,Richardt HG,Schneider S,Kelm M, Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels. Coronary artery disease. 2007 Nov [PubMed PMID: 17925610]
[37]
Vermeersch P,Agostoni P,Verheye S,Van den Heuvel P,Convens C,Van den Branden F,Van Langenhove G, Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. Journal of the American College of Cardiology. 2007 Jul 17 [PubMed PMID: 17631219]
[40]
Nairooz R,Saad M,Dhillon AS,Yousaf H,Awar L,Mehra A,Matthews RV,Shavelle D,Clavijo L, Long-term outcomes of drug-eluting stents versus bare metal stents in saphenous vein graft interventions. Evidence from a meta-analysis of randomized controlled trials. Cardiovascular revascularization medicine : including molecular interventions. 2018 Dec [PubMed PMID: 30078629]
[43]
Laham RJ,Carrozza JP,Berger C,Cohen DJ,Kuntz RE,Baim DS, Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems. Journal of the American College of Cardiology. 1996 Oct [PubMed PMID: 8837554]
[45]
Benoit E,O'Donnell TF Jr,Kitsios GD,Iafrati MD, Improved amputation-free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement. Journal of vascular surgery. 2012 Mar [PubMed PMID: 22209608]